CSIR conducting 20-odd trials in race for COVID drug: DG
The Hindu
Breakthrough expected as trial with Sun Pharma inches towards completion
Council of Scientific & Industrial Research (CSIR) is presently conducting “20-odd” clinical studies with multiple industries including “five” clinical trials based on the ‘Ayush’ formulations on finding a drug to deal with COVID-19, disclosed Director-General Shekhar C. Mande on Monday. “We are taking up clinical trials tapping our traditional knowledge but from a modern science perspective for the first time in history. Another breakthrough is expected within a week or 10 days, as our clinical trial with Sun Pharma based on phyto-pharmaceuticals or plant extracts will be completed and if the results are promising, we will seek permissions for furthering research,” he said.More Related News